{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:17:59Z","timestamp":1788218279745,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02878-z","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:02:49Z","timestamp":1788217369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intratumoral Mycobacterium abscessus promotes cytidine deaminase mutagenesis in non-small cell lung cancer"],"prefix":"10.1038","volume":"11","author":[{"given":"Xun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Peng","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan-Qi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Hua","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5532-5257","authenticated-orcid":false,"given":"Wan-Yan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Jun","family":"Bie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Long","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Feng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1857-2798","authenticated-orcid":false,"given":"Quan-Xin","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"2878_CR1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc4552","volume":"371","author":"GD Sepich-Poore","year":"2021","unstructured":"Sepich-Poore, G. D. et al. The microbiome and human cancer. Science 371, eabc4552 (2021).","journal-title":"Science"},{"key":"2878_CR2","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman, D. et al. The human tumor microbiome is composed of tumor type\u2013specific intracellular bacteria. Science 368, 973\u2013980 (2020).","journal-title":"Science"},{"key":"2878_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ccell.2022.01.003","volume":"40","author":"A Alam","year":"2022","unstructured":"Alam, A. et al. Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer. Cancer Cell 40, 153\u2013167.e11 (2022).","journal-title":"Cancer Cell"},{"key":"2878_CR4","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.chom.2023.04.010","volume":"31","author":"S-S Jiang","year":"2023","unstructured":"Jiang, S.-S. et al. Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer. Cell Host Microbe 31, 781\u2013797.e9 (2023).","journal-title":"Cell Host Microbe"},{"key":"2878_CR5","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.cell.2024.01.004","volume":"187","author":"K Fu","year":"2024","unstructured":"Fu, K. et al. Streptococcus anginosus promotes gastric inflammation, atrophy, and tumorigenesis in mice. Cell 187, 882\u2013896.e17 (2024).","journal-title":"Cell"},{"key":"2878_CR6","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","volume":"176","author":"C Jin","year":"2019","unstructured":"Jin, C. et al. Commensal microbiota promote lung cancer development via \u03b3\u03b4 T cells. Cell 176, 998\u20131013.e16 (2019).","journal-title":"Cell"},{"key":"2878_CR7","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41586-024-08087-4","volume":"634","author":"C-K Mo","year":"2024","unstructured":"Mo, C.-K. et al. Tumour evolution and microenvironment interactions in 2D and 3D space. Nature 634, 1178\u20131186 (2024).","journal-title":"Nature"},{"key":"2878_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61709-x","volume":"16","author":"E Persi","year":"2025","unstructured":"Persi, E. et al. Genome-level selection in tumors as a universal marker of resistance to therapy. Nat. Commun. 16, 6535 (2025).","journal-title":"Nat. Commun."},{"key":"2878_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31\u201346 (2022).","journal-title":"Cancer Discov."},{"key":"2878_CR10","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1126\/science.aab4082","volume":"349","author":"I Martincorena","year":"2015","unstructured":"Martincorena, I. & Campbell, P. J. Somatic mutation in cancer and normal cells. Science 349, 1483\u20131489 (2015).","journal-title":"Science"},{"key":"2878_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94\u2013101 (2020).","journal-title":"Nature"},{"key":"2878_CR12","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41586-022-04972-y","volume":"607","author":"M Petljak","year":"2022","unstructured":"Petljak, M. et al. Mechanisms of APOBEC3 mutagenesis in human cancer cells. Nature 607, 799\u2013807 (2022).","journal-title":"Nature"},{"key":"2878_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41576-022-00459-8","volume":"23","author":"R Pecori","year":"2022","unstructured":"Pecori, R., Di Giorgio, S., Paulo Lorenzo, J. & Nina Papavasiliou, F. Functions and consequences of AID\/APOBEC-mediated DNA and RNA deamination. Nat. Rev. Genet. 23, 505\u2013518 (2022).","journal-title":"Nat. Rev. Genet."},{"key":"2878_CR14","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.cell.2022.02.027","volume":"185","author":"A Fu","year":"2022","unstructured":"Fu, A. et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell 185, 1356\u20131372.e26 (2022).","journal-title":"Cell"},{"key":"2878_CR15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3390\/microorganisms13020447","volume":"13","author":"RLDS Lira","year":"2025","unstructured":"Lira, R. L. D. S. et al. Mycobacterium abscessus subsp. massiliense: biofilm formation, host immune response, and therapeutic strategies. Microorganisms 13, 447 (2025).","journal-title":"Microorganisms"},{"key":"2878_CR16","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41579-020-0331-1","volume":"18","author":"MD Johansen","year":"2020","unstructured":"Johansen, M. D., Herrmann, J.-L. & Kremer, L. Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus. Nat. Rev. Microbiol. 18, 392\u2013407 (2020).","journal-title":"Nat. Rev. Microbiol."},{"key":"2878_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.tibtech.2016.08.002","volume":"35","author":"C R\u00fcter","year":"2017","unstructured":"R\u00fcter, C. & Schmidt, M. A. Cell-penetrating bacterial effector proteins: better tools than targets. Trends Biotechnol. 35, 109\u2013120 (2017).","journal-title":"Trends Biotechnol."},{"key":"2878_CR18","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41579-022-00763-4","volume":"20","author":"P Chandra","year":"2022","unstructured":"Chandra, P., Grigsby, S. J. & Philips, J. A. Immune evasion and provocation by Mycobacterium tuberculosis. Nat. Rev. Microbiol. 20, 750\u2013766 (2022).","journal-title":"Nat. Rev. Microbiol."},{"key":"2878_CR19","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s41579-025-01201-x","volume":"23","author":"DF Warner","year":"2025","unstructured":"Warner, D. F., Barczak, A. K., Gutierrez, M. G. & Mizrahi, V. Mycobacterium tuberculosis biology, pathogenicity and interaction with the host. Nat. Rev. Microbiol. 23, 788\u2013804 (2025).","journal-title":"Nat. Rev. Microbiol."},{"key":"2878_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25203-4","volume":"12","author":"S Oh","year":"2021","unstructured":"Oh, S. et al. Genotoxic stress and viral infection induce transient expression of APOBEC3A and pro-inflammatory genes through two distinct pathways. Nat. Commun. 12, 4917 (2021).","journal-title":"Nat. Commun."},{"key":"2878_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa2630","volume":"347","author":"S Liu","year":"2015","unstructured":"Liu, S. et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347, aaa2630 (2015).","journal-title":"Science"},{"key":"2878_CR22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nmeth.4580","volume":"15","author":"CM Potel","year":"2018","unstructured":"Potel, C. M., Lin, M.-H., Heck, A. J. R. & Lemeer, S. Widespread bacterial protein histidine phosphorylation revealed by mass spectrometry-based proteomics. Nat. Methods 15, 187\u2013190 (2018).","journal-title":"Nat. Methods"},{"key":"2878_CR23","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nature26140","volume":"555","author":"SK Hindupur","year":"2018","unstructured":"Hindupur, S. K. et al. The protein histidine phosphatase LHPP is a tumour suppressor. Nature 555, 678\u2013682 (2018).","journal-title":"Nature"},{"key":"2878_CR24","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/j.molcel.2022.05.007","volume":"82","author":"T Hunter","year":"2022","unstructured":"Hunter, T. A journey from phosphotyrosine to phosphohistidine and beyond. Mol. Cell 82, 2190\u20132200 (2022).","journal-title":"Mol. Cell"},{"key":"2878_CR25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.cell.2015.05.046","volume":"162","author":"SR Fuhs","year":"2015","unstructured":"Fuhs, S. R. et al. Monoclonal 1- and 3-phosphohistidine antibodies: new tools to study histidine phosphorylation. Cell 162, 198\u2013210 (2015).","journal-title":"Cell"},{"key":"2878_CR26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2010644118","volume":"118","author":"R Kalagiri","year":"2021","unstructured":"Kalagiri, R. et al. Structural basis for differential recognition of phosphohistidine-containing peptides by 1-pHis and 3-pHis monoclonal antibodies. Proc. Natl. Acad. Sci. USA 118, e2010644118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2878_CR27","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1158\/2159-8290.CD-22-1131","volume":"13","author":"CM Adams","year":"2023","unstructured":"Adams, C. M. et al. Targeted MDM2 degradation reveals a new vulnerability for p53-inactivated triple-negative breast cancer. Cancer Discov. 13, 1210\u20131229 (2023).","journal-title":"Cancer Discov."},{"key":"2878_CR28","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41586-023-06303-1","volume":"620","author":"H Isozaki","year":"2023","unstructured":"Isozaki, H. et al. Therapy-induced APOBEC3A drives evolution of persistent cancer cells. Nature 620, 393\u2013401 (2023).","journal-title":"Nature"},{"key":"2878_CR29","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1158\/1541-7786.MCR-23-0247","volume":"21","author":"KE Krueger","year":"2023","unstructured":"Krueger, K. E. Neo-darwinian principles exemplified in cancer genomics. Mol. Cancer Res. 21, 1251\u20131260 (2023).","journal-title":"Mol. Cancer Res."},{"key":"2878_CR30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41575-022-00587-w","volume":"19","author":"E Zhuravleva","year":"2022","unstructured":"Zhuravleva, E., O\u2019Rourke, C. J. & Andersen, J. B. Mutational signatures and processes in hepatobiliary cancers. Nat. Rev. Gastroenterol. Hepatol. 19, 367\u2013382 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2878_CR31","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41571-024-00932-9","volume":"21","author":"J Budczies","year":"2024","unstructured":"Budczies, J. et al. Tumour mutational burden: clinical utility, challenges and emerging improvements. Nat. Rev. Clin. Oncol. 21, 725\u2013742 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2878_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-022-01304-4","volume":"8","author":"L Yang","year":"2023","unstructured":"Yang, L., Li, A., Wang, Y. & Zhang, Y. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy. Signal Transduct. Target. Ther. 8, 35 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2878_CR33","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/j.ccell.2023.08.012","volume":"41","author":"N-N Liu","year":"2023","unstructured":"Liu, N.-N. et al. The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells. Cancer Cell 41, 1927\u20131944.e9 (2023).","journal-title":"Cancer Cell"},{"key":"2878_CR34","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.cmi.2023.08.035","volume":"30","author":"C Cristancho-Rojas","year":"2024","unstructured":"Cristancho-Rojas, C. et al. Epidemiology of Mycobacterium abscessus. Clin. Microbiol. Infect. 30, 712\u2013717 (2024).","journal-title":"Clin. Microbiol. Infect."},{"key":"2878_CR35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/microorganisms7030090","volume":"7","author":"RC Lopeman","year":"2019","unstructured":"Lopeman, R. C., Harrison, J., Desai, M. & Cox, J. A. G. Mycobacterium abscessus: environmental bacterium turned clinical nightmare. Microorganisms 7, 90 (2019).","journal-title":"Microorganisms"},{"key":"2878_CR36","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1080\/14787210.2016.1238304","volume":"14","author":"F Mougari","year":"2016","unstructured":"Mougari, F. et al. Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment. Expert Rev. Anti Infect. Ther. 14, 1139\u20131154 (2016).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"2878_CR37","doi-asserted-by":"publisher","first-page":"5868","DOI":"10.3390\/ijms20235868","volume":"20","author":"G Degiacomi","year":"2019","unstructured":"Degiacomi, G. et al. Mycobacterium abscessus, an emerging and worrisome pathogen among cystic fibrosis patients. Int. J. Mol. Sci. 20, 5868 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"2878_CR38","doi-asserted-by":"publisher","first-page":"140196","DOI":"10.1016\/j.ijbiomac.2025.140196","volume":"299","author":"T Mondal","year":"2025","unstructured":"Mondal, T. et al. Fusobacterium nucleatum modulates the Wnt\/\u03b2-catenin pathway in colorectal cancer development. Int. J. Biol. Macromol. 299, 140196 (2025).","journal-title":"Int. J. Biol. Macromol."},{"key":"2878_CR39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.tim.2022.08.010","volume":"31","author":"N Wang","year":"2023","unstructured":"Wang, N. & Fang, J.-Y. Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer. Trends Microbiol. 31, 159\u2013172 (2023).","journal-title":"Trends Microbiol."},{"key":"2878_CR40","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/prd.12426","volume":"89","author":"T Alon-Maimon","year":"2022","unstructured":"Alon-Maimon, T., Mandelboim, O. & Bachrach, G. Fusobacterium nucleatum and cancer. Periodontol. 2000 89, 166\u2013180 (2022).","journal-title":"Periodontol. 2000"},{"key":"2878_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","volume":"9","author":"P Malfertheiner","year":"2023","unstructured":"Malfertheiner, P. et al. Helicobacter pylori infection. Nat. Rev. Dis. Primer 9, 19 (2023).","journal-title":"Nat. Rev. Dis. Primer"},{"key":"2878_CR42","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2108655","volume":"14","author":"A Nabavi-Rad","year":"2022","unstructured":"Nabavi-Rad, A. et al. The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management. Gut Microbes 14, 2108655 (2022).","journal-title":"Gut Microbes"},{"key":"2878_CR43","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.ccell.2024.08.019","volume":"42","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer. Cancer Cell 42, 1729\u20131746.e8 (2024).","journal-title":"Cancer Cell"},{"key":"2878_CR44","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.ccell.2025.07.012","volume":"43","author":"M Xie","year":"2025","unstructured":"Xie, M. et al. Tumor-resident probiotic Clostridium butyricum improves aPD-1 efficacy in colorectal cancer models by inhibiting IL-6-mediated immunosuppression. Cancer Cell 43, 1885\u20131901.e10 (2025).","journal-title":"Cancer Cell"},{"key":"2878_CR45","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41574-024-00990-0","volume":"20","author":"Z Ahmad","year":"2024","unstructured":"Ahmad, Z., Kahloan, W. & Rosen, E. D. Transcriptional control of metabolism by interferon regulatory factors. Nat. Rev. Endocrinol. 20, 573\u2013587 (2024).","journal-title":"Nat. Rev. Endocrinol."},{"key":"2878_CR46","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41586-024-07614-7","volume":"631","author":"D Fisch","year":"2024","unstructured":"Fisch, D. et al. Molecular definition of the endogenous Toll-like receptor signalling pathways. Nature 631, 635\u2013644 (2024).","journal-title":"Nature"},{"key":"2878_CR47","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1126\/science.adi8828","volume":"389","author":"DA Hoagland","year":"2025","unstructured":"Hoagland, D. A. et al. Macrophage-derived oncostatin M repairs the lung epithelial barrier during inflammatory damage. Science 389, 169\u2013175 (2025).","journal-title":"Science"},{"key":"2878_CR48","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.abc2061","volume":"369","author":"J Major","year":"2020","unstructured":"Major, J. et al. Type I and III interferons disrupt lung epithelial repair during recovery from viral infection. Science 369, 712\u2013717 (2020).","journal-title":"Science"},{"key":"2878_CR49","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41586-024-07806-1","volume":"633","author":"VK Ninh","year":"2024","unstructured":"Ninh, V. K. et al. Spatially clustered type I interferon responses at injury borderzones. Nature 633, 174\u2013181 (2024).","journal-title":"Nature"},{"key":"2878_CR50","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1126\/science.1232458","volume":"339","author":"L Sun","year":"2013","unstructured":"Sun, L., Wu, J., Du, F., Chen, X. & Chen, Z. J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786\u2013791 (2013).","journal-title":"Science"},{"key":"2878_CR51","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molcel.2022.12.007","volume":"83","author":"S Yang","year":"2023","unstructured":"Yang, S. et al. Metabolic enzyme UAP1 mediates IRF3 pyrophosphorylation to facilitate innate immune response. Mol. Cell 83, 298\u2013313.e8 (2023).","journal-title":"Mol. Cell"},{"key":"2878_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011742","volume":"19","author":"W-W Li","year":"2023","unstructured":"Li, W.-W. et al. Tyrosine phosphorylation of IRF3 by BLK facilitates its sufficient activation and innate antiviral response. PLOS Pathog. 19, e1011742 (2023).","journal-title":"PLOS Pathog."},{"key":"2878_CR53","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1126\/science.1126867","volume":"312","author":"S Mukherjee","year":"2006","unstructured":"Mukherjee, S. et al. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312, 1211\u20131214 (2006).","journal-title":"Science"},{"key":"2878_CR54","doi-asserted-by":"publisher","first-page":"14046","DOI":"10.1073\/pnas.0504466102","volume":"102","author":"DW Kim","year":"2005","unstructured":"Kim, D. W. et al. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc. Natl. Acad. Sci. USA 102, 14046\u201314051 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2878_CR55","doi-asserted-by":"publisher","first-page":"13725","DOI":"10.1073\/pnas.0907200106","volume":"106","author":"J Ge","year":"2009","unstructured":"Ge, J. et al. A Legionella type IV effector activates the NF-\u03baB pathway by phosphorylating the I\u03baB family of inhibitors. Proc. Natl. Acad. Sci. USA 106, 13725\u201313730 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2878_CR56","doi-asserted-by":"publisher","first-page":"102399","DOI":"10.1016\/j.mib.2023.102399","volume":"76","author":"AF Alvarez","year":"2023","unstructured":"Alvarez, A. F. & Georgellis, D. Environmental adaptation and diversification of bacterial two-component systems. Curr. Opin. Microbiol. 76, 102399 (2023).","journal-title":"Curr. Opin. Microbiol."},{"key":"2878_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40095-2","volume":"14","author":"GD Sankhe","year":"2023","unstructured":"Sankhe, G. D. et al. Sequestration of histidine kinases by non-cognate response regulators establishes a threshold level of stimulation for bacterial two-component signaling. Nat. Commun. 14, 4483 (2023).","journal-title":"Nat. Commun."},{"key":"2878_CR58","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/s41592-022-01524-0","volume":"19","author":"NM Leijten","year":"2022","unstructured":"Leijten, N. M., Heck, A. J. R. & Lemeer, S. Histidine phosphorylation in human cells; a needle or phantom in the haystack? Nat. Methods 19, 827\u2013828 (2022).","journal-title":"Nat. Methods"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02878-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02878-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02878-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:02:50Z","timestamp":1788217370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02878-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2878"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02878-z","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"10 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"355"}}